StonvexLoading…
StonvexStonvexStonvexCore line items from NYAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $400.43M | $314.01M | $235.49M | $173.51M |
Operating Income | $37.56M | $3.10M | $-12.38M | $-34.04M |
Net Income | $35.52M | $-5.63M | $-15.89M | $-37.51M |
EPS (Diluted) | $0.94 | $-0.16 | $-0.48 | $-1.14 |
Total Assets | $852.64M | $432.89M | $323.86M | $230.49M |
Total Liabilities | $621.62M | $267.65M | $226.27M | $125.85M |
Cash & Equivalents | $319.54M | $83.13M | $38.39M | $33.88M |
Free Cash Flow OCF − CapEx | $34.96M | $39.82M | $8.19M | $-29.07M |
Shares Outstanding | Not available | Not available | Not available | Not available |